Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines
在南非 HVTN 100 中,对健康 HIV 未感染成年人进行 12 个月加强免疫后的安全性和免疫反应:ALVAC-HIV (vCP2438) 和二价 C 亚型 gp120/MF59 疫苗的随机双盲安慰剂对照试验
期刊:PLoS Medicine
影响因子:9.9
doi:10.1371/journal.pmed.1003038
Laher, Fatima; Moodie, Zoe; Cohen, Kristen W; Grunenberg, Nicole; Bekker, Linda-Gail; Allen, Mary; Frahm, Nicole; Yates, Nicole L; Morris, Lynn; Malahleha, Mookho; Mngadi, Kathryn; Daniels, Brodie; Innes, Craig; Saunders, Kevin; Grant, Shannon; Yu, Chenchen; Gilbert, Peter B; Phogat, Sanjay; DiazGranados, Carlos A; Koutsoukos, Marguerite; Van Der Meeren, Olivier; Bentley, Carter; Mkhize, Nonhlanhla N; Pensiero, Michael N; Mehra, Vijay L; Kublin, James G; Corey, Lawrence; Montefiori, David C; Gray, Glenda E; McElrath, M Juliana; Tomaras, Georgia D